Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (11-20 of 600) with videos related to

Pageof 60
Sort By:
Hamostaseologie|December 17, 2009
Platelets and vascular diseaseMartin Moser, Christoph Bode
Hamostaseologie|March 29, 2018
Martin Moser, Christoph Bode
European Heart Journal|May 29, 2007
STEMI and NSTEMI: the dangerous brothersChristoph Bode, Andreas Zirlik
Hamostaseologie|October 7, 2008
[Vascular biology and blood coagulation]Martin Moser, Christoph Bode
Herz|May 20, 2005
[Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?]Ingo Ahrens, Christoph Bode
Journal of Thrombosis and Thrombolysis|May 15, 2010
Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?Martin Moser, Christoph Bode
Current Drug Discovery Technologies|August 16, 2011
New parenteral anticoagulants: focus on factor Xa and thrombin inhibitorsIngo Ahrens, Christoph Bode
Deutsche Medizinische Wochenschrift (1946)|May 6, 2021
[Interdisciplinary aspects of oral anticoagulation with NOACs in atrial fibrillation]Daniel Dürschmied, Christoph Bode
European Heart Journal|May 14, 2011
Redemption by RE-DEEM?Martin Moser, Christoph Bode
Thrombosis and Haemostasis|December 8, 2004
Pharmacotherapy in cardiovascular diseases and vascular interventionsKarlheinz Peter, Christoph Bode
Pageof 60

Showing results (11-20 of 600) with videos related to

Sort By:
Pageof 60
Hamostaseologie|December 17, 2009
Platelets and vascular diseaseMartin Moser, Christoph Bode
Hamostaseologie|March 29, 2018
Martin Moser, Christoph Bode
European Heart Journal|May 29, 2007
STEMI and NSTEMI: the dangerous brothersChristoph Bode, Andreas Zirlik
Hamostaseologie|October 7, 2008
[Vascular biology and blood coagulation]Martin Moser, Christoph Bode
Herz|May 20, 2005
[Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?]Ingo Ahrens, Christoph Bode
Journal of Thrombosis and Thrombolysis|May 15, 2010
Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?Martin Moser, Christoph Bode
Current Drug Discovery Technologies|August 16, 2011
New parenteral anticoagulants: focus on factor Xa and thrombin inhibitorsIngo Ahrens, Christoph Bode
Deutsche Medizinische Wochenschrift (1946)|May 6, 2021
[Interdisciplinary aspects of oral anticoagulation with NOACs in atrial fibrillation]Daniel Dürschmied, Christoph Bode
European Heart Journal|May 14, 2011
Redemption by RE-DEEM?Martin Moser, Christoph Bode
Thrombosis and Haemostasis|December 8, 2004
Pharmacotherapy in cardiovascular diseases and vascular interventionsKarlheinz Peter, Christoph Bode
Pageof 60